Antibiotic therapy of pneumonia in the obese patient: dosing and delivery.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3940399)

Published in Curr Opin Infect Dis on April 01, 2014

Authors

Hasan M Al-Dorzi1, Shmylan A Al Harbi, Yaseen M Arabi

Author Affiliations

1: aIntensive Care Department, King Abdulaziz Medical City - Riyadh bCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences cMedical Surgical Intensive Care Unit, King Abdulaziz Medical City - Riyadh dCollege of Pharmacy, King Saud bin Abdulaziz University for Health Sciences.

Articles cited by this

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis (2011) 6.71

Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42

Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria. Chest (2013) 2.25

Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill. Antimicrob Agents Chemother (2012) 1.88

Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility. Crit Care Med (2013) 1.63

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care (2011) 1.54

Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ (2010) 1.33

Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care (2013) 1.31

Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med (2011) 1.24

Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care (2013) 1.20

Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med (2013) 1.15

Impaired wound healing predisposes obese mice to severe influenza virus infection. J Infect Dis (2011) 1.12

Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia. J Antimicrob Chemother (2012) 1.06

Dosing of antibiotics in obesity. Curr Opin Infect Dis (2012) 1.00

Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults. Antimicrob Agents Chemother (2011) 0.99

Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients. Antimicrob Agents Chemother (2012) 0.99

The effect of obesity on antibiotic treatment failure: a historical cohort study. Pharmacoepidemiol Drug Saf (2013) 0.96

Case-control study of drug monitoring of β-lactams in obese critically ill patients. Antimicrob Agents Chemother (2012) 0.93

Cefepime dosing in the morbidly obese patient population. Obes Surg (2012) 0.93

Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock. Antimicrob Agents Chemother (2012) 0.91

Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrob Agents Chemother (2011) 0.91

Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients. Int J Antimicrob Agents (2012) 0.89

Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrob Agents Chemother (2013) 0.88

Effect of gastric bypass surgery on azithromycin oral bioavailability. J Antimicrob Chemother (2012) 0.88

Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery. J Antimicrob Chemother (2011) 0.87

Pharmacokinetics of intravenous linezolid in moderately to morbidly obese adults. Antimicrob Agents Chemother (2012) 0.85

Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients. J Antimicrob Chemother (2011) 0.85

Evaluation of the effect of obesity on voriconazole serum concentrations. J Antimicrob Chemother (2012) 0.84

Creatinine-based estimations of kidney function are unreliable in obese kidney donors. J Transplant (2012) 0.84

Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects? J Antimicrob Chemother (2012) 0.83

Steady-state pharmacokinetics and pharmacodynamics of meropenem in morbidly obese patients hospitalized in an intensive care unit. J Clin Pharmacol (2013) 0.83

Dosing of piperacillin/tazobactam in a morbidly obese patient. J Antimicrob Chemother (2011) 0.81

Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review. Pharmacotherapy (2013) 0.80

Underdosing of common antibiotics for obese patients in the ED. Am J Emerg Med (2011) 0.80

Evaluation of extended interval dosing aminoglycosides in the morbidly obese population. Adv Pharmacol Sci (2013) 0.79

Levofloxacin weight-adjusted dosing and pharmacokinetic disposition in a morbidly obese patient. J Antimicrob Chemother (2011) 0.78

Should we abandon vancomycin for treatment of methicillin-resistant Staphylococcus aureus pneumonia? Still questions to answer. Clin Infect Dis (2012) 0.77

Articles by these authors

Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med (2011) 11.69

High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med (2013) 6.56

Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA (2008) 6.39

Health risks at the Hajj. Lancet (2006) 3.18

Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med (2014) 3.01

Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ (2011) 1.64

Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care (2013) 1.31

Critical care management of severe traumatic brain injury in adults. Scand J Trauma Resusc Emerg Med (2012) 1.30

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. Emerg Infect Dis (2016) 0.94

The results of a 6-year epidemiologic surveillance for ventilator-associated pneumonia at a tertiary care intensive care unit in Saudi Arabia. Am J Infect Control (2012) 0.90

Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. Int J Infect Dis (2013) 0.90

Impact of computerized physician order entry (CPOE) system on the outcome of critically ill adult patients: a before-after study. BMC Med Inform Decis Mak (2011) 0.89

Advantages and disadvantages of etomidate use for intubation of patients with sepsis. Pharmacotherapy (2012) 0.89

Research experience, interest and perceived barriers of clinical staff working at the Intensive Care Department of a tertiary care academic hospital in Saudi Arabia. Middle East J Anaesthesiol (2013) 0.84

Global participation in core data sets for emerging pathogens. Am J Respir Crit Care Med (2015) 0.83

Even mild hyperlactatemia is associated with increased mortality in critically ill patients. Crit Care (2013) 0.83

Association between statin therapy and outcomes in critically ill patients: a nested cohort study. BMC Clin Pharmacol (2011) 0.82

Renal failure as a risk factor for venous thromboembolism in critically Ill patients: a cohort study. Thromb Res (2013) 0.81

Treatment of ventilator-associated pneumonia and ventilator-associated tracheobronchitis in the intensive care unit. A national survey of clinicians and pharmacists in Saudi Arabia. Saudi Med J (2015) 0.80

Intensive insulin therapy versus conventional insulin therapy for critically ill trauma patients admitted to ICU. Middle East J Anaesthesiol (2010) 0.79

What is the optimal blood glucose target in critically ill patients? A nested cohort study. Ann Thorac Med (2011) 0.79

Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial. Ann Saudi Med (2016) 0.78

Nosocomial infective endocarditis in critically ill patients: a report of three cases and review of the literature. Int J Infect Dis (2004) 0.78

In-hospital mortality among a cohort of cirrhotic patients admitted to a tertiary hospital. Saudi J Gastroenterol (2011) 0.78

Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients. Medicine (Baltimore) (2015) 0.78

Trauma profile at a tertiary intensive care unit in Saudi Arabia. Ann Saudi Med (2012) 0.78

Life-threatening infections in medically immunocompromised patients. Crit Care Clin (2013) 0.78

End-of-life practices in a tertiary intensive care unit in Saudi Arabia. Anaesth Intensive Care (2012) 0.78

Intra-abdominal pressure and abdominal perfusion pressure in cirrhotic patients with septic shock. Ann Intensive Care (2012) 0.77

Etomidate and mortality in cirrhotic patients with septic shock. BMC Clin Pharmacol (2011) 0.77

Permissive Underfeeding or Standard Enteral Feeding in Critical Illness. N Engl J Med (2015) 0.77

Serum procalcitonin in cirrhotic patients with septic shock: relationship with adrenal insufficiency and clinical outcomes. Clin Lab (2014) 0.76

Magnesium supplementation and the potential association with mortality rates among critically ill non-cardiac patients. Saudi Med J (2006) 0.76

Knowledge of thromboprophylaxis guidelines pre- and post-didactic lectures during a venous thromboembolism awareness day at a tertiary-care hospital. Ann Thorac Med (2013) 0.75

Demographics and outcomes of critically ill patients transferred from other hospitals to a tertiary care academic referral center in Saudi Arabia. Ann Intensive Care (2013) 0.75

Scientific misconduct and medical publishing. Ann Thorac Med (2007) 0.75

Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis. Crit Care Med (2017) 0.75

Outbreaks in the adult ICUs. Curr Opin Infect Dis (2017) 0.75

Severe hypoglycemia in peritoneal dialysis patients due to overestimation of blood glucose by the point-of-care glucometer. Saudi J Kidney Dis Transpl (2011) 0.75

An introduction to medical simulation. Saudi Med J (2009) 0.75

Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection. Neurosciences (Riyadh) (2017) 0.75

Nursing workload and perception about intensive insulin therapy in critically ill adult patients. Saudi Med J (2010) 0.75

Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching. Crit Care Med (2017) 0.75